Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...

It was almost an extraordinary scene in front of the White House. As Tesla shares have been tanking since the year began, President Donald Trump held remarks outside of the White House with the ...

The TSLA stock was up close to 5% on Tuesday. In the past one month, the stock has gone down around 30%. Wedbush Securities ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...

Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to ...

At a time when sentiment in the stock is at its most vulnerable in months, Taneja deliberately chose to cash in more of his ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla is ...